445871238
22 Jul 2019
United States FDA Approves Mercks RECARBRIO imipenem cilastatin and relebactam For the Treatment of Adults with Complicated Urinary Tract and Complicated Intra-Abdominal Bacterial Infections Where Limited or No Alternative Treatment Options Are Available, United states
N/A
Banking, Finance, Insurance and Securities (BFIS) Tenders , Healthcare and Medical Tenders , Services Tenders
Procurement News
Click for more details
If you have forgotten your User ID or Password, then please contact the TendersInfo Customercare by Email on customercare@tendersinfo.com.